Lynne I. Wagner
- Oncology top 0.5%
- Cancer survivorship and care 67
- Cancer Treatment and Pharmacology 44
- Otorhinolaryngology top 0.5%
-
- Cancer-related cognitive impairment studies 38
-
- Childhood Cancer Survivors' Quality of Life 32
- Genetics top 1%
-
- Multiple Myeloma Research and Treatments 32
-
- Breast Cancer Treatment Studies 18
-
- Palliative Care and End-of-Life Issues 17
-
- Economic and Financial Impacts of Cancer 15
- Co-authors
- David CellaPaul B. JacobsenJennifer L. BeaumontAl B. BensonMario E. LacoutureFengmin ZhaoJoanna M. BrellHiginia R. Cárdenes
- Journals
- Journal of Clinical Oncology (75 papers)SHILAP Revista de lepidopterología (1 paper)Blood (12 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Lynne I. Wagner
226 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 4.1k
- Otorhinolaryngology 487
- Pulmonary and Respiratory Medicine 2.0k
- Pediatrics, Perinatology and Child Health 1.2k
- Genetics 653
Countries citing papers authored by Lynne I. Wagner
This map shows the geographic impact of Lynne I. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne I. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne I. Wagner more than expected).
Fields of papers citing papers by Lynne I. Wagner
This network shows the impact of papers produced by Lynne I. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne I. Wagner. The network helps show where Lynne I. Wagner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lynne I. Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 0 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 46 | |
| 12 | 2019 | 50 | |
| 13 | 2018 | 29 | |
| 14 | 2018 | 13 | |
| 15 | E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Groupbreakdown → | 2017 | 317 |
| 16 | E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. | 2015 | 9 |
| 17 | 2014 | 138 | |
| 18 | Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trialbreakdown → | 2011 | 604 |
| 19 | 2010 | 216 | |
| 20 | 1992 | 6 |
About Lynne I. Wagner
Lynne I. Wagner is a scholar working on Oncology, Hematology and Otorhinolaryngology, having authored 243 papers that have together received 7.2k indexed citations. Recurring topics across this work include Cancer survivorship and care (67 papers), Cancer Treatment and Pharmacology (44 papers), Cancer-related cognitive impairment studies (38 papers), Childhood Cancer Survivors' Quality of Life (32 papers), Multiple Myeloma Research and Treatments (32 papers), Breast Cancer Treatment Studies (18 papers), Palliative Care and End-of-Life Issues (17 papers) and Economic and Financial Impacts of Cancer (15 papers). The work is most often cited by research in Oncology (4.1k citations), Otorhinolaryngology (487 citations) and Pulmonary and Respiratory Medicine (2.0k citations). Lynne I. Wagner has collaborated with scholars based in United States, Canada and France. Frequent co-authors include David Cella, Paul B. Jacobsen, Jennifer L. Beaumont, Al B. Benson, Mario E. Lacouture, Fengmin Zhao, Joanna M. Brell, Higinia R. Cárdenes, Christopher H. Crane and Patrick J. Flynn. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.